GLP Podcast: Overdose Crisis—Illicit Opioids Spread Like Drug-Resistant Bacteria?
In this episode of the Facts and Fallacies podcast, hosts Cameron English and Dr. Liza Lockwood dissect the rapid evolution of illicit opioids, likening it to microbial drug resistance. They explain how prohibition drives black‑market producers to splice ever‑more potent synthetics—fentanyl, carfentanil, and newer analogs—into drugs sold as prescription pills, leading to fatal overdoses at minuscule doses. Dr. Lockwood, a medical toxicologist, details the clinical challenges these ultra‑potent opioids pose, such as the need for higher naloxone doses and difficulties in detection, while also contextualizing the crisis with historical parallels like the Opium Wars and modern policy debates on harm reduction versus strict enforcement.
GLP Podcast: Does Industry Funding Corrupt Science? The ‘Shill Gambit,’ Debunked
In this episode of the Facts and Fallacies podcast, hosts Cameron English and Dr. Liza Lockwood dissect the "shill gambit"—the ad hominem tactic of dismissing scientific arguments by accusing the speaker of industry bias. They argue that such accusations sideline...
GLP Podcast: Everybody’s Wrong About RFK, Jr.’s Dietary Guidelines
In this episode, Dr. Liza Lockwood and Cameron J. English dissect the new Dietary Guidelines for Americans, which promote "real food"—full‑fat dairy, fruits, vegetables, and more protein—while still limiting saturated fat to under 10% of calories. They explain how media...
GLP Podcast: Evolutionary Mismatch. Is Civilization Wrecking Our Health?
The episode examines the evolutionary mismatch theory, arguing that modern industrialized life bombards humans with chronic low‑level stressors unlike the intermittent challenges faced by our hunter‑gatherer ancestors, leading to physical ailments such as hypertension, immune decline, and reduced fertility, as...
GLP Podcast: Ketamine—Miracle Depression Treatment, or Recreational Nightmare?
The episode examines ketamine’s rise from a battlefield anesthetic to an FDA‑approved treatment (esketamine) for treatment‑resistant depression, highlighting its rapid antidepressant effects and potential to reduce suicidal thoughts. Experts discuss the drug’s significant risks—including addiction, dissociation, blood‑pressure spikes, bladder damage,...